LEXISCAN

NDC 0469-6501 · Astellas Pharma US, Inc.

Generic nameregadenoson

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)REGADENOSON

Strength.08 mg/mL

Pharmacologic classAdenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]

Marketing categoryNDA

Packages

0469-6501-89 — 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89)

J2785 — Injection, regadenoson, 0.1 mg Medicare Part B payment limit (ASP + 6%): $2.79

FDA lists these products with the same active ingredient.

10135-803 — Regadenoson, 16729-477 — REGADENOSON, 36000-364 — regadenoson, 51662-1448 — LEXISCAN(R) (REGADENOSON), 55150-443 — regadenoson, 60505-6116 — regadenoson, 60505-6288 — regadenoson, 68083-175 — Regadenoson, 71288-201 — Regadenoson, 83032-001 — Regadenoson, 85742-012 — Regadenoson

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.